| 2025-03-12 | +39.7% | M&A | Seeking Alpha | Roche-Zealand deal is the latest to boost obesity space |
| 2025-03-12 | +39.7% | news | Seeking Alpha | Roche And Zealand Team Up To Develop Petrelintide |
| 2025-03-12 | +39.7% | M&A | Seeking Alpha | Roche, Zealand Pharma enter $5.3B license deal for obesity treatment |
| 2026-03-06 | -31.1% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Discusses Top Line Phase II Results for ZUPREME-1 Trial of Petrelintide in Obesity Transcript |
| 2026-03-05 | -29.1% | news | Seeking Alpha | Roche succeeds in mid-stage trial for obesity drug developed with Zealand |
| 2026-04-17 | +11.5% | earnings | MarketBeat | Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Still a Buy? - MarketBeat |
| 2026-04-07 | -10.5% | earnings | MarketBeat | Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Should You Sell? - MarketBeat |
| 2026-03-25 | +9.7% | news | Simply Wall St. | Assessing Zealand Pharma (CPSE:ZEAL) Valuation As New Cambridge Research Hub Expands AI Drug Discovery |
| 2025-05-08 | -9.3% | earnings | Seeking Alpha | Zealand Pharma A/S 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-08 | -9.3% | earnings | Seeking Alpha | Zealand Pharma reports Q1 results |
| 2026-03-24 | +8.2% | news | GlobeNewswire | Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation |
| 2026-04-21 | -7.9% | earnings | MarketBeat | Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading Up 8.2% - Should You Buy? - MarketBeat |
| 2025-08-14 | +7.7% | earnings | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Q2 2025 Earnings Call Transcript |
| 2025-08-14 | +7.7% | news | Seeking Alpha | Zealand Pharma reports 1H results |
| 2026-01-21 | +5.9% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-03-12 | +5.1% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference - Slideshow |
| 2026-03-12 | +5.1% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference - Slideshow - Seeking Alpha |
| 2026-03-11 | +4.7% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript |
| 2026-04-22 | -4.4% | legal | GlobeNewswire | Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons |
| 2026-04-22 | -4.4% | earnings | MarketBeat | Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - What's Next? - MarketBeat |
| 2024-07-30 | +4.4% | news | Seeking Alpha | Zealand Pharma: A Bit Frothy (OTCMKTS:ZLDPF) - Seeking Alpha |
| 2025-09-25 | -4.3% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents At Bank Of America Global Healthcare Conference 2025 Transcript |
| 2026-03-31 | -3.7% | news | GlobeNewswire | Total number of shares and voting rights in Zealand Pharma as of March 31, 2026 |
| 2026-04-10 | -3.7% | earnings | MarketBeat | Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Strong Trading Volume - Still a Buy? - MarketBeat |
| 2026-03-26 | +3.5% | news | GlobeNewswire | Resolutions from Zealand Pharma's Annual General Meeting 2026 |
| 2026-02-19 | -3.2% | earnings | Seeking Alpha | Zealand Pharma A/S 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-19 | -3.2% | earnings | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript |
| 2026-02-19 | -3.2% | news | Seeking Alpha | Zealand Pharma reports FY results |
| 2025-05-09 | -3.1% | earnings | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call Transcript |
| 2025-05-16 | +2.1% | news | Seeking Alpha | Zealand: Promising Roche-Partnered Obesity Drug Developer - But Stock Is Pricey |
| 2025-05-16 | +2.1% | news | Seeking Alpha | Zealand: Promising Roche-Partnered Obesity Drug Developer - But Stock Is Pricey (ZLDPF) - Seeking Alpha |
| 2026-04-14 | -2.0% | executive | GlobeNewswire | Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations |
| 2026-03-19 | +1.9% | news | MT Newswires | Zealand Pharma Announces Share Capital Increase |
| 2026-03-19 | +1.9% | news | GlobeNewswire | Zealand Pharma increases its share capital as a result of the exercise of employee warrants |
| 2025-05-15 | -1.1% | executive | Seeking Alpha | Zealand CEO: Oral weight loss meds are not the future for treating obesity |
| 2022-09-25 | +1.0% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Zealand Pharma AS (ZLDPF) - Zacks Investment Research |
| 2025-03-08 | -0.9% | news | Seeking Alpha | Weight-loss drug battle: Who are the latest players involved |
| 2026-04-06 | -0.8% | earnings | MarketBeat | Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - What's Next? - MarketBeat |
| 2026-03-09 | -0.7% | news | GlobeNewswire | Zealand Pharma to participate in upcoming investor conferences in March 2026 |
| 2026-03-09 | -0.7% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Discusses Top Line Phase II Results for ZUPREME-1 Trial of Petrelintide in Obesity - Slideshow |
| 2026-03-09 | -0.7% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Discusses Top Line Phase II Results for ZUPREME-1 Trial of Petrelintide in Obesity - Slideshow (OTCMKTS:ZLDPF) 2026-03-09 - Seeking Alpha |
| 2025-04-24 | +0.6% | news | Seeking Alpha | Zealand Pharma gains as trial for Roche-partnered obesity drug starts |
| 2025-12-11 | -0.5% | analyst | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Analyst/Investor Day - Slideshow |
| 2025-12-11 | -0.5% | M&A | Seeking Alpha | Zealand inks deal with Chinese pharma to develop oral drugs for metabolic diseases |
| 2025-12-15 | +0.4% | analyst | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Analyst/Investor Day Transcript |
| 2025-11-14 | -0.3% | news | Seeking Alpha | Zealand Pharma reports results |
| 2025-11-14 | -0.3% | earnings | Seeking Alpha | Zealand Pharma A/S 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-14 | -0.3% | earnings | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Q3 2025 Earnings Call Transcript |
| 2026-04-19 | +0.2% | expansion | GlobeNewswire | Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 |
| 2026-01-15 | -0.2% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2025-09-05 | +0.0% | news | Seeking Alpha | Zealand Pharma A/S (ZLDPF) Presents at Cantor Global Healthcare Conference 2025 Transcript |